References
- Vikram B, Strong EW, Manolatos S, Mishra UB. Improved survival in carcinoma of the nasopharynx. Head Neck Surg 1984; 7: 123–128
- Muir CS, Shanmugaratnam K. Cancer of the Nasopharynx. Munksgaard, Amsterdam 1967
- Haghbin M, Kramer S, Patchefsky AS, et al. Carcinoma of the nasopharynx. A 25-year study. Am J Clin Oncol 1985; 8: 384–392
- Bedwinck JM, Perez CA, Keys DJ. Analysis of failures after definitive irradiation for epidermoid carcinoma of the nasopharynx. Cancer 1980; 45: 2725–2729
- Mesic JB, Fletcher GH, Goepfert H. Megavoltage irradiation of epithelial tumors of the nasopharynx. Int J Radiat Oncol Biol Phys 1981; 7: 144–453
- Vikram B, Mishra UB, Strong EW, Manolatm S. Patterns of failure in carcinoma of the nasopharynx: I. Failure at the primary site. Int J Radiat Oncol Biol Phys 1985; 11: 1455–1459
- Merino OR, Lindberg RD, Fletcher GH. An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 1977; 40: 145–151
- Hill BT, Shaw HJ, Dalley VM, Price LA. 24-hour combination chemotherapy without cisplatin in patients with recurrent or metastatic head and neck cancer. Am J Clin Oncol 1984; 7: 335–340
- Taylor SG. Head and neck cancer. Cancer Chemotherapy 1983. The EORTC Cancer Chemotherapy Annual 5, HM. Pinedo, BA. Chabner. Elsevier, Amsterdam 1983; 291–306
- Hong WK, Bromer R. Chemotherapy in head and neck cancer. N Engl J Med 1983; 308: 75–79
- Errin TJ, Clark JR, Weichselbaum RR. Multidisciplinary treatment of advanced squamous carcinoma of the head and neck. Semin Oncol 1985; 12: 71–78
- Hill BT, Price LA, Busby E, . Positive impact of initial 24-hour combination chemotherapy without cis-platinum on 5-year survival figures in advanced squamous cell carcinomas of the head and neck. Adjuvant Therapy of Cancer IV, SE. Jones, SE. Salmon, et al. Grune and Stratton, Orlando 1984; 97–106
- Price LA, Hill BT, MacRae K. Increased survival in stage III and IV squamous cell carcinomas of the head and neck using an initial 24-hour combination chemotherapy protocol without cisplatin: 6 year follow up. Primary Chemotherapy in Cancer Medicine. Progress in Clinical and Biological Research, DJT. Wagmr, GH. Blijham, JBE. Smeets, JA. Wils, R. Alan Liss. New York 1985; Volume 201: 159–167
- Price LA, Hill BT. Safe and effective induction chemotherapy without cisplatin for squamous cell carcinoma of the head and neck: impact on complete response rate and survival at five years following local therapy. Med Pediatr Oncol 1982; 10: 535–548
- Weichselbaum RR, Clark JR, Miller D, et al. Combined modality treatment of head and neck cancer with cisplatin, bleomycin, methotrexate-leucovorin chemotherapy. Cancer 1985; 55: 2149–2155
- Amrein PC, Weitzman SA. Treatment of squamous-cell carcinoma of the head and neck with cisplatin and 5-fluorouracil. J Clin Oncol 1985; 3: 1632–1639
- Perry DJ, Davis RK, Zajtchuk JR, Baumann JC. Vinblastine, bleomycin and cisplatin in the treatment of squamous carcinoma of the head and neck. Adjuvant Therapy of Cancer IV, SE. Jones, SE. Salmon. Grune and Stratton, Orlando 1984; 135–143
- Decker DA, Drelichman A, Al-Sarraf M, et al. Chemotherapy for nasopharyngeal carcinoma. A ten-year experience. Cancer 1983; 52: 602–605
- Hill BT, Pice LA, MacRae K. Importance of primary site in assessing chemotherapy response and seven-year survival data in advanced squamous cell carcinomas of the head and neck treated with initial combination chemotherapy without cisplatin. J Clin Oncol 1986; 4: 1340–1347
- Huang S-C, Lui LT, Lynn T-C. Nasopharyngeal cancer: Study III. A Review of 1206 patients treated with combined modalities. Int J Radiat Oncol Biol Phys 1985; 11: 1789–1793